MORPHOCEUTICALS
LIVE

Serial Number

97607631

Owner

Morphoceuticals, Inc.

Attorney

Norm J. Rich

Filing Date

Sep 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MORPHOCEUTICALS Trademark

Serial Number: 97607631 • Registration: 7395351

MORPHOCEUTICALS is a trademark filed by Morphoceuticals, Inc. on September 26, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Morphoceuticals, Inc. (3 trademarks)

Princeton Innovation Center BioLabs
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

September 26, 2022

Registration Date

May 28, 2024

Published for Opposition

March 12, 2024

Goods & Services

Downloadable computer software for use in database management in the field of regenerative medicine; downloadable computer programs for use in database management for assisting in machine learning in the field of regenerative medicine; computer hardware

Pharmaceutical preparations for use in tissue repair and organ and limb repair and regeneration and for use in the regeneration of stem cells; pharmaceutical preparations containing stem cells for use in tissue repair and organ and limb repair and regeneration; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants grown from stem cells; surgical implants grown from stem cells comprising living tissues; cells for medical or clinical use

Compilation and systemization of information into computer databases; data processing services in the field of healthcare and medical research

Stem cells for research or scientific purposes; chemical preparations for use in scientific research, other than medical or veterinary use, * all for use in relation to tissue, organ and limb repair and regeneration therapy; * diagnostic preparations for scientific or research use other than for medical use; media for cell culture for use in non-medical research laboratories; reagents for medical research use; reagents for scientific or medical research use

Medical services; veterinary services; healthcare services, namely, health care services in the field of regenerative medicine; medical services relating to the removal, treatment and processing of stem cells; medical and veterinary services relating to human and animal tissue, limb and organ regeneration; stem cell therapy services; stem cell storage services; stem cell bank services; fitting of artificial limbs, prosthetic devices and prostheses; fitting of artificial limbs; providing medical and medical clinical data analytics and bioinformatics services; providing health care data analytics and bioinformatics services

Surgical apparatus and instruments; medical apparatus and instruments for use in surgical procedures for tissue repair and organ and limb repair and regeneration; mechanically and surgically implanted medical apparatus comprised of artificial material and natural, non-living materials for use in the healing of truncated limbs and for use in tissue repair and organ and limb repair and regeneration and for the regeneration of stem cells; artificial limbs; limb compression instruments, namely, therapeutic compression wraps; hosiery, namely, prosthetic sheaths for limbs; prosthetic sleeves for limbs; prosthetic socks for limbs

Scientific and technological services, namely, research and design in the fields of regenerative medicine, tissue repair, organ and limb repair and regeneration, and the regeneration of stem cells; industrial analysis and research services in the field of regenerative medicine; design and development of computer software and hardware; providing online, non-downloadable software for use in database management in the field of regenerative medicine; biomedical research services; data mining services; bioinformatics services, namely, biological data analysis for scientific research purposes; biological, medical and clinical data analysis, namely, compiling data for research purposes in the field of regenerative medicine; consultancy regarding generation of biological, medical and clinical data; computational analysis of scientific and medical data; stem cell research services; biological research and medical research; clinical research in the field of regenerative medicine; veterinary research services; scientific research for medical purposes in the field of regenerative medicine; medical research laboratory services; providing medical and scientific research information in the field of stem cells, tissue, limb and organ regeneration and clinical trials; provision of information and data relating to medical and veterinary research; compiling statistical data for medical, veterinary and clinical research purposes; * all of the aforesaid limited to use in relation to tissue, organ and limb repair and regeneration therapy *

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Sep 9, 2025 NURC
AMENDMENT UNDER SECTION 7 - PROCESSED
Aug 15, 2025 A7OK
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Aug 12, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Feb 15, 2025 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 10, 2025 APRE
TEAS SECTION 7 REQUEST RECEIVED
Aug 22, 2024 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 28, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 28, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
ELECTRONIC RECORD REVIEW COMPLETE
Feb 7, 2024 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 26, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 19, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 19, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 19, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 19, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 8, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 8, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 8, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 8, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 8, 2024 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 9, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 9, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 12, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 10, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 14, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2022 NWOS
NEW APPLICATION ENTERED
Sep 29, 2022 NWAP